News Archive

Roche Buys IL-2 Technology From Good, Which Forms New Firm Bonum

Scrip

Sep 07, 2022 Media

Good Therapeutics being acquired by Roche for $250M

The Business Journals

Sep 07, 2022 Media

Bonum to continue Good work after $250M cash acquisition deal with Roche

BioWorld

Sep 7, 2022 Media

Roche shells out $250M to acquire Good Therapeutics and its preclinical oncology program

MedCityNews

Sep 7, 2022 Media

Roche to acquire Good Therapeutics’ lead drug program for $250M, plus milestone payments

GeekWire

Sep 7, 2022 Media

Roche pays $250 million to acquire Good Therapeutics and its preclinical cancer therapy

STAT

Sep 7, 2022 Media

Good Therapeutics sells PD-1 IL-2 program to Roche for $250M and will march on with a similar name, but in Latin

Endpoints News

Sep 7, 2022 Media

Roche snaps up PD-1-focused Good Therapeutics for $250M; ‘Sky’s the limit’ for spinout

Fierce Biotech

Sep 7, 2022 Media